Compare NKTR & ANDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTR | ANDE |
|---|---|---|
| Founded | 1990 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | 1996 | 2005 |
| Metric | NKTR | ANDE |
|---|---|---|
| Price | $71.90 | $71.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $146.67 | $75.00 |
| AVG Volume (30 Days) | ★ 1.2M | 313.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.03% |
| EPS Growth | N/A | ★ 12.93 |
| EPS | N/A | ★ 0.97 |
| Revenue | $307,711,000.00 | ★ $11,008,928,000.00 |
| Revenue This Year | N/A | $7.28 |
| Revenue Next Year | N/A | $3.57 |
| P/E Ratio | ★ N/A | $74.28 |
| Revenue Growth | ★ 86.00 | N/A |
| 52 Week Low | $21.02 | $31.84 |
| 52 Week High | $109.00 | $82.11 |
| Indicator | NKTR | ANDE |
|---|---|---|
| Relative Strength Index (RSI) | 59.67 | 56.12 |
| Support Level | $64.30 | $69.23 |
| Resistance Level | $76.67 | $74.24 |
| Average True Range (ATR) | 4.21 | 1.98 |
| MACD | 1.55 | 0.25 |
| Stochastic Oscillator | 77.06 | 96.47 |
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.